UCSF Alumni Confront COVID-19
We asked on social media for alumni to share their pandemic stories. Here’s a selection of submissions that came in from across the country.
University of California San Francisco
Give to UCSFWe asked on social media for alumni to share their pandemic stories. Here’s a selection of submissions that came in from across the country.
Why are more men than women dying of COVID-19? Scientist Faranak Fattahi, PhD, has found a clue.
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.
Pharmacist Katherine Yang, PharmD, raced to get a new, lifesaving drug approved for emergency treatment of COVID-19.
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
What’s it like – as a clinician, researcher, student, or hospital staffer – to confront a lethal disease unlike any you’ve seen before? In this special series, professionals across UCSF share first-person accounts of COVID-19 that reveal grit, ingenuity, and resolve in the face of fear.
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
Scientists have developed a prototype tool based on 3D facial imaging that could shorten years undergoing medical tests and waiting for a diagnosis for rare genetic diseases.
BRIDGE is an interface available to physicians during their encounter with patients.
Vigorously embracing their leadership roles, our faculty members are coming together to tackle this public health crisis from all angles.
To meet the pressing need for personal protective equipment for frontline health care workers, a multidisciplinary team has mobilized UCSF’s 3D-printing infrastructure to engineer and produce thousands of face shields.
UCSF researchers are working on deep-brain stimulation technology that can be customized to the patient’s brain make up and their own brain’s feedback.
For 15 years, nobody could figure out what was making a young woman so sick. Then neurologist Michael Wilson, MD, tried a radical new test.
Scientists at UCSF are exploring how we can improve our bodies – now and in the future – with science that sounds like sci-fi.
Advances in medicine and public health have dramatically extended the lifespan of hearts, lungs, and other vital organs. But for women, the ovaries remain a stubborn exception. That may soon change, says fertility expert Marcelle Cedars.
Basic scientist Zena Werb, who has studied cancer cells in UCSF labs for more than four decades, shares her take on the future of cancer medicine.
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.
Scientists have documented the influence of information overload on attention, perception, memory, decision-making, and emotional regulation. But the same technologies contributing to the cognition crisis could help solve it, argues neuroscientist Adam Gazzaley.
We are entering an era of brain-machine interfaces and genome-editing technology. When we can govern the very biology that makes us who we are, what will it mean to be human?
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
Brain imaging of pathological tau-protein reliably predicts the location of future brain atrophy in Alzheimer’s patients a year or more in advance.
With the rise of “direct-to-consumer” DNA tests, investigating your genes is easier than ever. But taking one of these tests may not be right for you, says UCSF professor Kathryn Phillips, PhD, who studies new health care technologies.
From international awards for high-caliber research to groundswell movements for social change, this past year was an eventful one for the UCSF community.
With a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco, and the University of Washington have launched the Weill Neurohub to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.
UC San Francisco and the Translational Research Institute for Space Health are co-sponsoring the inaugural Space Health Innovation Conference to advance research and scientific understanding of how space travel impacts health.
An algorithm developed by scientists at UC San Francisco and UC Berkeley did better than two out of four expert radiologists at finding tiny brain hemorrhages in head scans—an advance that one day may help doctors treat patients with TBI, strokes and aneurysms.